Building AI tools for healthcare means playing a completely different game than your typical SaaS startup. BioticsAI CEO Robhy Bustami sat down on the Build Mode podcast to walk through what that actually looks like day to day.
The conversation with host Isabelle Johannessen focused on the unglamorous reality of operating in a highly regulated space. We're talking FDA approval processes, compliance frameworks, and the kind of red tape that can turn a six month product cycle into a multi year journey.
For anyone thinking about bringing AI into healthcare, the key insight here is about team management. Bustami discussed how BioticsAI keeps engineers and product people engaged when they can't just ship fast and iterate. That's a real challenge when you're used to the move fast mentality of typical tech companies.
The regulatory burden in healthcare isn't going away, even as AI capabilities accelerate. If anything, we're likely to see more oversight as these tools get closer to clinical decision making. That means founders in this space need a different playbook than their peers building consumer or enterprise AI products.
What makes this relevant now is the wave of AI health companies raising money and making promises about transforming medicine. The gap between a working prototype and an FDA cleared product you can actually sell is massive, and not every team is prepared for that reality.
